Allianz cooperating as DOJ probes Structured Alpha Funds
The U.S. Department of Justice has begun an investigation relating to Allianz Global Investors’ Structured Alpha Funds, following litigation pending in U.S. courts on the matter, German insurer Allianz (ALVG.DE) said on Sunday.
China’s factory activity in July grows at slowest pace since Feb 2020
China’s factory activity expanded in July at the slowest pace in 17 months as higher raw material costs, equipment maintenance and extreme weather weighed on business activity, adding to concerns about a slowdown in the world’s second-biggest economy.
Beyond the meme: finance gets serious on going viral
Ian Rogers used to be in charge of digital strategy for luxury fashion group LVMH. Now he has a new mission: to sprinkle some aspirational glitz on to French cryptocurrency company Ledger.
Schroders’ assets near $1 trillion, aided by low interest rates
Low interest rates are bolstering money managers like Schroders (SDR.L), its chief executive said on Thursday as the British firm posted a jump in first-half profits and record high assets under management of 700.4 billion pounds ($977.7 billion).
Marketmind: A step closer to Fed taper, quelle surprise!
The main reveal from the Fed’s statement was that it was inching closer to a policy normalisation announcement and that came as no surprise to anyone.
UK mortgage lending booms but consumers stay wary about debt
British mortgage lending showed a record surge in June as home-buyers rushed to qualify for a tax break before it was scaled back, but other data added to signs that a rise in COVID-19 cases in recent weeks slowed the broader economic recovery from lockdown.
Fed says economic recovery remains on track despite COVID-19 surge
The U.S. economic recovery is still on track despite a rise in coronavirus infections, the Federal Reserve said on Wednesday in a new policy statement that remained upbeat and flagged ongoing talks around the eventual withdrawal of monetary policy support.
AstraZeneca COVID-19 sales jump as drugmaker navigates vaccine challenges
Second-quarter sales of AstraZeneca’s (AZN.L) COVID-19 vaccine more than tripled to $894 million from the first quarter, but the drugmaker on Thursday again delayed its U.S. application for approval as it gathers more data for submissions.
Chinese stocks in tentative bounce, Fed in no hurry to taper
Asian shares managed a semblance of calm on Thursday as the U.S. Federal Reserve signalled it was in no rush to taper stimulus, though the mood was fragile as investors waited to see if Beijing could stem the recent bloodletting in Chinese shares.
Facebook’s slowdown warning hangs over strong ad sales, while Zuckerberg talks ‘metaverse’
Facebook Inc (FB.O) said on Wednesday it expects revenue growth to “decelerate significantly,” sending the social media giant’s shares down 3.5% in extended trading even as it reported strong ad sales.
